Changes to the website
Sponsored By
Cedars-Sinai Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

This is a list of chages to the website.

You can Subscribe to our RSS FEED: Subscribe to our RSS feed, which delivers brain tumor news and additions to the website via RSS.
(Click HERE for details on RSS.)

Displaying items 26 to 50 of about 5050

Previous 25           Next 25
Website Changes
06/24/2020 Musella Foundation Copay Program now closed to new patients
06/24/2020 New class of precision medicine strips cancer of its DNA defenses
06/24/2020 DelMar Pharmaceuticals Presents Positive Interim Data on VAL-083 Demonstrating Favorable Outcomes in Both Newly- Diagnosed and Recurrent GBM at the AACR Virtual Annual Meeting II
06/22/2020 Exploiting Cancer’s Tactics to Make Cancer a Manageable Chronic Disease
06/21/2020 Brain Tumor Webinars continue tonight! Sunday 6/21/2020 7pm Eastern Time
06/18/2020 Gallagher, Colleagues Introduce Bipartisan Promising Pathways Act
06/15/2020 Karyopharm Announces Dosing of First Patient in a Phase 1/2 Study of Selinexor in Combination with Standard of Care Therapy for Patients with Newly Diagnosed or Recurrent Glioblastoma
06/15/2020 Global Post-Marketing Safety Surveillance of Tumor Treating Fields (TTFields) in Patients With High-Grade Glioma in Clinical Practice
06/15/2020 The Musella Foundation Awards 2 Brain Tumor Research Grants
06/15/2020 Cancer Vaccine Plus Adoptive T-cell Therapy Placed on Fast Track
06/13/2020 Brain Tumor Webinar Series continues tonight! 6/14/2020
06/13/2020 Global Coalition for Adaptive Research (GCAR) Selects DelMar Pharmaceuticals` VAL-083 to Participate in the GBM AGILE Pivotal Study, an Adaptive Clinical Trial Platform in Glioblastoma Multiforme
06/07/2020 Brain Tumor Webinars continue tonight!
06/05/2020 The McDowell Family Lost A Child To Cancer And Now They Are Creating a Tourist Attraction to Fund Research– So Why Are Some Of The Neighbors So Angry?
06/02/2020 Novocure Announces Launch of MyLink™ to Enable Patient-Guided, Remote Download of Optune® Usage Data
06/02/2020 First Patient Treated in Phase 1 Clinical Trial Of Incysus Therapeutics Gamma Delta (?d) T Cell Immunotherapy for Patients With Newly Diagnosed Glioblastoma
06/02/2020 Factors Affecting Survival in Glioblastoma: A 10-year Single-Center Experience From Saudi Arabia
06/01/2020 Phase 2a study to evaluate the safety, pharmacokinetics, and clinical activity of the PI3K / mTOR inhibitor GDC-0084 given to glioblastoma (GBM) patients with unmethylated MGMT promotor status
05/29/2020 ASCO Brain Tumor Abstracts
05/29/2020 ONC201 in previously irradiated pediatric H3 K27M-mutant glioma or newly diagnosed DIPG.
05/29/2020 Temozolomide Antagonizes Oncolytic Immunovirotherapy in Glioblastoma
05/29/2020 Brain Tumor Webinars!
05/29/2020 Al Musella`s ASCO Highlights Part 2
05/29/2020 Al Musella`s ASCO Hightlights
05/29/2020 Musella Foundation Awards Pediatric Brain Tumor Research Grant!



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740